MedPath

Impact of Neuropsychological Evaluation on Epilepsy Treatment

Phase 2
Conditions
Epilepsy
Interventions
Behavioral: Neuropsychological testing
Registration Number
NCT03202082
Lead Sponsor
University of South Florida
Brief Summary

The present study aims to expand the evidence base of neuropsychological services in the context of medical management of epilepsy, examining whether treatment outcome and patient satisfaction with medical care are significantly improved when neuropsychological evaluation is included as an additional component of medical care within a comprehensive epilepsy center. All participants will complete an initial survey and a follow-up survey regarding views towards their epilepsy treatment. Participants will be randomized into one of two groups. One group will be given a neuropsychological battery in addition to the survey. The primary study hypothesis is that the addition of neuropsychological services to treatment-as-usual will result in significant improvements in (a) satisfaction with medical care, (b) patient perceived treatment outcome, and (c) physician-rated medical compliance. The secondary hypothesis is that participants who undergo neuropsychological evaluation will be generally satisfied with their experience with neuropsychological services.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 18 years of age or older
  • experiencing some degree of epilepsy-related symptoms, but not of such severity as to preclude them from being able to provide consent or undergo neuropsychological assessment (requiring extended inpatient treatment, severely aphasic, or MMSE score < 25)
Exclusion Criteria
  • Previously undergone neuropsychological testing
  • Currently pursuing surgical treatment for epilepsy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Neuropsychological testingNeuropsychological testingParticipants from this group will be administered a neuropsychological battery in addition to the initial and follow-up surveys
Primary Outcome Measures
NameTimeMethod
Epilepsy Outcome Study Survey2-4 months

A brief questionnaire regarding the participants views on their epilepsy treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of South Florida

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath